On June 26, 2025 University of Maryland, Baltimore President Bruce Jarrell and University of Maryland, College Park President Darryll Pines discussed the challenges facing higher education today and how they are working together to overcome them. In this Virtual Face to Face program a live audience was able to pose questions about university-based research, international students, student finance, and more.

Could a new class of drugs rebalance the body and prevent excessive inflammation?Paul Shapiro, PhD, professor at the University of Maryland School of Pharmacy and partner Jeffrey Hasday, MD, professor at the University of Maryland School of Medicine are developing a class of drugs that may be able to reset the natural balance of inflammation and prevent a number of serious diseases. The secret is protein kinases, enzymes that regulate how various proteins interact and alter how they function.🧪 Breakthroughs Can’t Wait: UMB research drives innovation, improves lives, and tackles global challenges. But we can’t do it without continued support.🔗 Learn more and support research that saves lives: https://www.umaryland.edu/breakthroughs#BreakthroughsCantWaitUMB #InflammationResearch #DrugDiscovery #ProteinKinase, #MedicalBreakthrough #ChronicInflammation #BiomedicalResearch #PharmaceuticalScience #TranslationalMedicine #UMBresearch #EnzymeTherapy #InflammationTreatment, #FutureOfMedicine #LifeSavingResearch, #HealthInnovation

Protein kinases help regulate inflammation — but what happens when their activity goes unchecked?At the University of Maryland, Baltimore, researchers Paul Shapiro, PhD, and Jeffrey Hasday, MD, are exploring how adjusting kinase activity may help reduce the severity of inflammation-related diseases.Watch how this breakthrough could lead to new strategies for improving long-term health. #ProteinKinases #HealthResearch #PharmacyInnovation #InflammationScience #MedicalBreakthrough #BreakthroughsCantWaitUMB

What if we could help the body manage inflammation before it becomes dangerous? At the University of Maryland, Baltimore, researchers Paul Shapiro, PhD, and Jeffrey Hasday, MD, are studying protein kinases — enzymes that regulate immune signaling. Their work could lead to breakthroughs in reducing acute respiratory distress syndrome (ARDS) and related health issues.#BreakthroughsCantWaitUMB #ARDS #MedicalResearch #Inflammation #PharmaceuticalScience #ImmuneBalance #BreakthroughsCantWaitUMB

What if we could reset the balance between inflammation and anti-inflammation in the body?That’s exactly what researchers Paul Shapiro, PhD (University of Maryland School of Pharmacy), and Jeffrey Hasday, MD (University of Maryland School of Medicine), are working toward.By exploring protein kinases—enzymes involved in regulating inflammation—they’re investigating ways to support long-term health and conditions related to immune overreaction, such as respiratory and muscular disorders.#BreakthroughsCantWaitUMB #InflammationResearch #ChronicPain #NIH

Lia Mejia, MSW '25, reflects on the advice to keep herself grounded in this conversation with University of Maryland, Baltimore Provost and VP Dr. Roger J. Ward, EdD, JD, MSL, MPA. Mejia graduated this spring from the University of Maryland School of Social Work with her master's degree.#Classof2025 #UMBgrad #SocialWork